JOHNSON CONTROLS INTERNATION (JCI)

IE00BY7QL619 - Common Stock

68.77  +2.05 (+3.07%)

After market: 68.78 +0.01 (+0.01%)

Fundamental Rating

3

Taking everything into account, JCI scores 3 out of 10 in our fundamental rating. JCI was compared to 40 industry peers in the Building Products industry. JCI may be in some trouble as it scores bad on both profitability and health. While showing a medium growth rate, JCI is valued expensive at the moment. JCI also has an excellent dividend rating.



3

1. Profitability

1.1 Basic Checks

In the past year JCI was profitable.
In the past year JCI had a positive cash flow from operations.
In the past 5 years JCI has always been profitable.
Each year in the past 5 years JCI had a positive operating cash flow.

1.2 Ratios

JCI's Return On Assets of 3.90% is on the low side compared to the rest of the industry. JCI is outperformed by 72.50% of its industry peers.
With a Return On Equity value of 10.83%, JCI perfoms like the industry average, outperforming 42.50% of the companies in the same industry.
JCI has a worse Return On Invested Capital (4.97%) than 75.00% of its industry peers.
Measured over the past 3 years, the Average Return On Invested Capital for JCI is significantly below the industry average of 13.86%.
Industry RankSector Rank
ROA 3.9%
ROE 10.83%
ROIC 4.97%
ROA(3y)3.97%
ROA(5y)5.38%
ROE(3y)9.97%
ROE(5y)12.45%
ROIC(3y)6.58%
ROIC(5y)5.48%

1.3 Margins

JCI's Profit Margin of 6.32% is on the low side compared to the rest of the industry. JCI is outperformed by 70.00% of its industry peers.
JCI's Profit Margin has declined in the last couple of years.
JCI has a worse Operating Margin (7.52%) than 75.00% of its industry peers.
JCI's Operating Margin has improved in the last couple of years.
JCI has a Gross Margin (32.84%) which is comparable to the rest of the industry.
In the last couple of years the Gross Margin of JCI has remained more or less at the same level.
Industry RankSector Rank
OM 7.52%
PM (TTM) 6.32%
GM 32.84%
OM growth 3Y10%
OM growth 5Y3.77%
PM growth 3Y34.64%
PM growth 5Y-5.67%
GM growth 3Y0.28%
GM growth 5Y0.43%

2

2. Health

2.1 Basic Checks

The Return on Invested Capital (ROIC) is below the Cost of Capital (WACC), so JCI is destroying value.
Compared to 1 year ago, JCI has less shares outstanding
The number of shares outstanding for JCI has been reduced compared to 5 years ago.
JCI has a better debt/assets ratio than last year.

2.2 Solvency

JCI has an Altman-Z score of 1.71. This is a bad value and indicates that JCI is not financially healthy and even has some risk of bankruptcy.
JCI's Altman-Z score of 1.71 is on the low side compared to the rest of the industry. JCI is outperformed by 90.00% of its industry peers.
JCI has a debt to FCF ratio of 8.61. This is a slightly negative value and a sign of low solvency as JCI would need 8.61 years to pay back of all of its debts.
With a Debt to FCF ratio value of 8.61, JCI is not doing good in the industry: 85.00% of the companies in the same industry are doing better.
JCI has a Debt/Equity ratio of 0.61. This is a neutral value indicating JCI is somewhat dependend on debt financing.
The Debt to Equity ratio of JCI (0.61) is worse than 62.50% of its industry peers.
Industry RankSector Rank
Debt/Equity 0.61
Debt/FCF 8.61
Altman-Z 1.71
ROIC/WACC0.71
WACC6.99%

2.3 Liquidity

JCI has a Current Ratio of 0.87. This is a bad value and indicates that JCI is not financially healthy enough and could expect problems in meeting its short term obligations.
JCI's Current ratio of 0.87 is on the low side compared to the rest of the industry. JCI is outperformed by 92.50% of its industry peers.
A Quick Ratio of 0.65 indicates that JCI may have some problems paying its short term obligations.
Looking at the Quick ratio, with a value of 0.65, JCI is doing worse than 92.50% of the companies in the same industry.
Industry RankSector Rank
Current Ratio 0.87
Quick Ratio 0.65

5

3. Growth

3.1 Past

The Earnings Per Share has been growing slightly by 3.37% over the past year.
Measured over the past 5 years, JCI shows a small growth in Earnings Per Share. The EPS has been growing by 4.49% on average per year.
The Revenue has been growing slightly by 2.83% in the past year.
The Revenue has been growing slightly by 2.75% on average over the past years.
EPS 1Y (TTM)3.37%
EPS 3Y15.87%
EPS 5Y4.49%
EPS Q2Q%4%
Revenue 1Y (TTM)2.83%
Revenue growth 3Y6.28%
Revenue growth 5Y2.75%
Sales Q2Q%0.19%

3.2 Future

Based on estimates for the next years, JCI will show a quite strong growth in Earnings Per Share. The EPS will grow by 10.74% on average per year.
The Revenue is expected to grow by 5.54% on average over the next years.
EPS Next Y3.25%
EPS Next 2Y8.6%
EPS Next 3Y10.08%
EPS Next 5Y10.74%
Revenue Next Year2.56%
Revenue Next 2Y3.72%
Revenue Next 3Y3.68%
Revenue Next 5Y5.54%

3.3 Evolution

When comparing the EPS growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.
The Revenue growth rate is accelerating: in the next years the growth will be better than in the last years.

1

4. Valuation

4.1 Price/Earnings Ratio

The Price/Earnings ratio is 20.41, which indicates a rather expensive current valuation of JCI.
Compared to the rest of the industry, the Price/Earnings ratio of JCI is on the same level as its industry peers.
When comparing the Price/Earnings ratio of JCI to the average of the S&P500 Index (24.41), we can say JCI is valued inline with the index average.
With a Price/Forward Earnings ratio of 16.66, JCI is valued correctly.
JCI's Price/Forward Earnings ratio is in line with the industry average.
JCI is valuated at similar levels of the S&P average when we compare the Price/Forward Earnings ratio to 20.59, which is the current average of the S&P500 Index.
Industry RankSector Rank
PE 20.41
Fwd PE 16.66

4.2 Price Multiples

Based on the Enterprise Value to EBITDA ratio, JCI is valued a bit more expensive than the industry average as 60.00% of the companies are valued more cheaply.
JCI's Price/Free Cash Flow ratio is rather expensive when compared to the industry. JCI is more expensive than 80.00% of the companies in the same industry.
Industry RankSector Rank
P/FCF 37.21
EV/EBITDA 18

4.3 Compensation for Growth

The high PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates an expensive valuation of the company.
PEG (NY)6.29
PEG (5Y)4.55
EPS Next 2Y8.6%
EPS Next 3Y10.08%

7

5. Dividend

5.1 Amount

With a Yearly Dividend Yield of 2.13%, JCI has a reasonable but not impressive dividend return.
Compared to an average industry Dividend Yield of 1.03, JCI pays a better dividend. On top of this JCI pays more dividend than 100.00% of the companies listed in the same industry.
JCI's Dividend Yield is comparable with the S&P500 average which is at 2.30.
Industry RankSector Rank
Dividend Yield 2.13%

5.2 History

The dividend of JCI is nicely growing with an annual growth rate of 6.83%!
JCI has been paying a dividend for at least 10 years, so it has a reliable track record.
JCI has not decreased its dividend in the past 5 years, so it has a somewhat stable track record.
Dividend Growth(5Y)6.83%
Div Incr Years3
Div Non Decr Years6

5.3 Sustainability

JCI pays out 59.17% of its income as dividend. This is a bit on the high side, but may be sustainable.
The dividend of JCI is growing, but earnings are growing more, so the dividend growth is sustainable.
DP59.17%
EPS Next 2Y8.6%
EPS Next 3Y10.08%

JOHNSON CONTROLS INTERNATION

NYSE:JCI (7/26/2024, 7:04:00 PM)

After market: 68.78 +0.01 (+0.01%)

68.77

+2.05 (+3.07%)

Chartmill FA Rating
GICS SectorIndustrials
GICS IndustryGroupCapital Goods
GICS IndustryBuilding Products
Earnings (Last)
Earnings (Next)
Inst Owners
Inst Owner Change
Ins Owners
Ins Owner Change
Market Cap46.33B
Analysts
Price Target
Dividend
Industry RankSector Rank
Dividend Yield 2.13%
Dividend Growth(5Y)
DP
Div Incr Years
Div Non Decr Years
Ex-Date
Surprises & Revisions
EPS beat(2)
Avg EPS beat(2)
Min EPS beat(2)
Max EPS beat(2)
EPS beat(4)
Avg EPS beat(4)
Min EPS beat(4)
Max EPS beat(4)
EPS beat(8)
Avg EPS beat(8)
EPS beat(12)
Avg EPS beat(12)
EPS beat(16)
Avg EPS beat(16)
Revenue beat(2)
Avg Revenue beat(2)
Min Revenue beat(2)
Max Revenue beat(2)
Revenue beat(4)
Avg Revenue beat(4)
Min Revenue beat(4)
Max Revenue beat(4)
Revenue beat(8)
Avg Revenue beat(8)
Revenue beat(12)
Avg Revenue beat(12)
Revenue beat(16)
Avg Revenue beat(16)
PT rev (1m)
PT rev (3m)
EPS NQ rev (1m)
EPS NQ rev (3m)
EPS NY rev (1m)
EPS NY rev (3m)
Revenue NQ rev (1m)
Revenue NQ rev (3m)
Revenue NY rev (1m)
Revenue NY rev (3m)
Valuation
Industry RankSector Rank
PE 20.41
Fwd PE 16.66
P/S
P/FCF
P/OCF
P/B
P/tB
EV/EBITDA
EPS(TTM)
EY
EPS(NY)
Fwd EY
FCF(TTM)
FCFY
OCF(TTM)
OCFY
SpS
BVpS
TBVpS
PEG (NY)6.29
PEG (5Y)4.55
Profitability
Industry RankSector Rank
ROA 3.9%
ROE 10.83%
ROCE
ROIC
ROICexc
ROICexgc
OM 7.52%
PM (TTM) 6.32%
GM 32.84%
FCFM
ROA(3y)
ROA(5y)
ROE(3y)
ROE(5y)
ROIC(3y)
ROIC(5y)
ROICexc(3y)
ROICexc(5y)
ROICexgc(3y)
ROICexgc(5y)
ROCE(3y)
ROCE(5y)
ROICexcg growth 3Y
ROICexcg growth 5Y
ROICexc growth 3Y
ROICexc growth 5Y
OM growth 3Y
OM growth 5Y
PM growth 3Y
PM growth 5Y
GM growth 3Y
GM growth 5Y
F-Score
Asset Turnover0.62
Health
Industry RankSector Rank
Debt/Equity 0.61
Debt/FCF
Debt/EBITDA
Cap/Depr
Cap/Sales
Interest Coverage
Cash Conversion
Profit Quality
Current Ratio 0.87
Quick Ratio 0.65
Altman-Z
F-Score
WACC
ROIC/WACC
Cap/Depr(3y)
Cap/Depr(5y)
Cap/Sales(3y)
Cap/Sales(5y)
Profit Quality(3y)
Profit Quality(5y)
High Growth Momentum
Growth
EPS 1Y (TTM)3.37%
EPS 3Y15.87%
EPS 5Y
EPS Q2Q%
EPS Next Y3.25%
EPS Next 2Y
EPS Next 3Y
EPS Next 5Y
Revenue 1Y (TTM)2.83%
Revenue growth 3Y6.28%
Revenue growth 5Y
Sales Q2Q%
Revenue Next Year
Revenue Next 2Y
Revenue Next 3Y
Revenue Next 5Y
EBIT growth 1Y
EBIT growth 3Y
EBIT growth 5Y
EBIT Next Year
EBIT Next 3Y
EBIT Next 5Y
FCF growth 1Y
FCF growth 3Y
FCF growth 5Y
OCF growth 1Y
OCF growth 3Y
OCF growth 5Y